Overall, our results indicate that the five validated hub genes (ASPN, MFAP4, PODN, HTRA1, and FAP) may contribute to the progression of DCM by regulating multiple immune cells. The gene discussed is ASPN; the disease is familial dilated cardiomyopathy.